Sayaka Kurokawa Selected Research

Sayaka Kurokawa Research Topics

12	Atrial Fibrillation 02/2024 - 07/2009
4	Heart Failure 05/2023 - 12/2017
2	Tachycardia (Tachyarrhythmias) 06/2023 - 01/2022
2	Atrial Remodeling 01/2023 - 01/2014
2	Cardiac Arrhythmias (Arrythmia) 01/2011 - 05/2010
1	Death (Near-Death Experience) 05/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2023
1	Atrial Flutter (Flutter, Atrial) 12/2022
1	Liver Diseases (Liver Disease) 07/2022
1	Bradycardia 03/2022
1	Apnea 03/2022
1	Diabetes Mellitus 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Malnutrition (Nutritional Deficiencies) 10/2021
1	Frailty 10/2021
1	Stroke (Strokes) 07/2019
1	Sick Sinus Syndrome 05/2018
1	Ventricular Fibrillation 01/2015
1	Ventricular Remodeling 01/2011
1	Torsades de Pointes (Torsade de Pointes) 05/2010

2	AnticoagulantsIBA 02/2024 - 07/2019
2	Anti-Arrhythmia AgentsIBA 06/2023 - 05/2010
1	Semaphorin-3AIBA 01/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2023
1	SteamIBA 12/2022
1	BilirubinIBA 07/2022
1	AlbuminsIBA 07/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Natriuretic PeptidesIBA 10/2021
1	anordiol (AF 45)IBA 09/2019
1	Adenosine Triphosphate (ATP)IBA 09/2019
1	AdiponectinIBA 12/2017
1	pro-brain natriuretic peptide (1-76)IBA 12/2017
1	Superoxides (Superoxide)IBA 01/2014
1	Potassium Channels (Potassium Channel)IBA 01/2014
1	Superoxide DismutaseIBA 01/2014
1	Buthionine SulfoximineIBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013
1	Glutathione (Reduced Glutathione)IBA 01/2011
1	Bepridil (Vascor)FDA Link 05/2010
1	pilsicainideIBA 07/2009

6	Catheter Ablation 07/2019 - 01/2016
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 05/2023 - 01/2015
2	Cardiac Resynchronization Therapy 05/2023 - 07/2022
2	Therapeutics 01/2022 - 10/2021
2	Catheters 01/2022 - 01/2016
1	Defibrillators (Defibrillator) 05/2023